Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin
Research ArticleClinical Studies

15-Year Survival Rates after Transurethral Resection and Radiochemotherapy or Radiation in Bladder Cancer Treatment

FRENS STEFFEN KRAUSE, BERNHARD WALTER, OLIVER JOSEF OTT, LOTHAR HÄBERLE, CHRISTIAN WEISS, CLAUS RÖDEL, BERND WULLICH and ROLF SAUER
Anticancer Research March 2011, 31 (3) 985-990;
FRENS STEFFEN KRAUSE
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: steffen.krause{at}akh.linz.at
BERNHARD WALTER
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
OLIVER JOSEF OTT
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
LOTHAR HÄBERLE
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
CHRISTIAN WEISS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
CLAUS RÖDEL
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
BERND WULLICH
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
ROLF SAUER
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 31 no. 3 985-990
PMID 
21498726

Published By 
International Institute of Anticancer Research
Print ISSN 
0250-7005
Online ISSN 
1791-7530
History 
  • Received December 3, 2011
  • Revision received February 10, 2011
  • Accepted February 11, 2011
  • Published online April 15, 2011.

Copyright & Usage 
Copyright© 2011 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved

Author Information

  1. FRENS STEFFEN KRAUSE1,2,*,
  2. BERNHARD WALTER1,*,
  3. OLIVER JOSEF OTT3,
  4. LOTHAR HÄBERLE4,
  5. CHRISTIAN WEISS5,
  6. CLAUS RÖDEL5,
  7. BERND WULLICH1 and
  8. ROLF SAUER3
  1. 1Department of Urology, University Clinic, Erlangen, Germany
  2. 2Department of Urology, AKH-General Hospital, Linz, Austria
  3. 3Department of Radiation Oncology, University Clinic, Erlangen, Germany
  4. 4Department of Biometry/Epidemiology, University of Erlangen/Nuremberg, Erlangen, Germany
  5. 5Department Radiation Therapy, University Clinic, Frankfurt, Germany
  1. ↵ Correspondence to: Prim. Priv.-Doz. Dr. Frens Steffen Krause, Department of Urology, AKH-General Hospital, Krankenhausstr. 9, 4020 Linz, Austria, Tel: +43 73278062243, Fax: +43 073278062246, e-mail: steffen.krause{at}akh.linz.at
View Full Text

Statistics from Altmetric.com

Cited By...

  • 67 Citations
  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

PreviousNext
Back to top

In this issue

Anticancer Research
Vol. 31, Issue 3
March 2011
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
15-Year Survival Rates after Transurethral Resection and Radiochemotherapy or Radiation in Bladder Cancer Treatment
(Your Name) has sent you a message from Anticancer Research
(Your Name) thought you would like to see the Anticancer Research web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
2 + 3 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
15-Year Survival Rates after Transurethral Resection and Radiochemotherapy or Radiation in Bladder Cancer Treatment
FRENS STEFFEN KRAUSE, BERNHARD WALTER, OLIVER JOSEF OTT, LOTHAR HÄBERLE, CHRISTIAN WEISS, CLAUS RÖDEL, BERND WULLICH, ROLF SAUER
Anticancer Research Mar 2011, 31 (3) 985-990;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
15-Year Survival Rates after Transurethral Resection and Radiochemotherapy or Radiation in Bladder Cancer Treatment
FRENS STEFFEN KRAUSE, BERNHARD WALTER, OLIVER JOSEF OTT, LOTHAR HÄBERLE, CHRISTIAN WEISS, CLAUS RÖDEL, BERND WULLICH, ROLF SAUER
Anticancer Research Mar 2011, 31 (3) 985-990;
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Patients and Methods
    • Results
    • Discussion
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

Cited By...

  • Long-Term Experience of Chemoradiotherapy Combined with Deep Regional Hyperthermia for Organ Preservation in High-Risk Bladder Cancer (Ta, Tis, T1, T2)
  • Clinical Results for Bladder Cancer Treated by Radiotherapy Without Concurrent Standard Chemotherapy
  • Google Scholar

More in this TOC Section

  • Efficacy of Platinum-based Chemotherapy for Platinum-sensitive Recurrent Ovarian Cancer During PARP Inhibitor Treatment: A Multicenter Retrospective Study
  • Uniformity Between Serological Biomarker Test, Esophago-gastro-duodenoscopy and Biopsy Histology in Triage of Upper Abdominal Symptoms in Gastroscopy Referral Patients
  • Renal Function With Enfortumab Vedotin in Metastatic Urothelial Carcinoma: A Multicenter Retrospective Study in Japan
Show more Clinical Studies
Anticancer Research

© 2026 Anticancer Research

Powered by HighWire